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Abstract
Background: Reduced level of arousal is commonly observed in medical admissions and may predict in-hospital
mortality. Delirium and reduced level of arousal are closely related. We systematically reviewed and conducted a
meta-analysis of studies in adult acute medical patients of the relationship between reduced level of arousal on
admission and in-hospital mortality.
Methods: We conducted a systematic review (PROSPERO: CRD42016022048), searching MEDLINE and EMBASE. We
included studies of adult patients admitted with acute medical illness with level of arousal assessed on admission
and mortality rates reported. We performed meta-analysis using a random effects model.
Results: From 23,941 studies we included 21 with 14 included in the meta-analysis. Mean age range was 33.4 - 83.8
years. Studies considered unselected general medical admissions (8 studies, n=13,039) or specific medical
conditions (13 studies, n=38,882). Methods of evaluating level of arousal varied. The prevalence of reduced level of
arousal was 3.1%-76.9% (median 13.5%). Mortality rates were 1.7%-58% (median 15.9%). Reduced level of arousal
was associated with higher in-hospital mortality (pooled OR 5.71; 95% CI 4.21-7.74; low quality evidence: high risk of
bias, clinical heterogeneity and possible publication bias).
Conclusions: Reduced level of arousal on hospital admission may be a strong predictor of in-hospital mortality. Most
evidence was of low quality. Reduced level of arousal is highly specific to delirium, better formal detection of
hypoactive delirium and implementation of care pathways may improve outcomes. Future studies to assess the impact
of interventions on in-hospital mortality should use validated assessments of both level of arousal and delirium.
Keywords: Mortality, Altered mental status, Delirium, Systematic review, Glasgow Coma Scale
Background
Rationale
Patients with reduced level of arousal on admission to
hospital are common [1–5]. A range of scales are used to
describe level of arousal; the Glasgow Coma Scale
(GCS)[6], AVPU (Alert, responds to Verbal stimulus,
responds to Painful stimulus and Unresponsive) [7],
Observational Scale of Level of Arousal (OSLA) [8] and the
Richmond Agitation-Sedation Scale (RASS) [9]. Reduced
level of arousal is associated with mortality [10–12]. How-
ever, study populations and methods of assessment of level
of arousal were heterogeneous.
Delirium is an acute, severe neuropsychiatric
syndrome characterised by acute onset and fluctuating
course, inattention and other changes in cognition, per-
ceptual deficits, and altered level of arousal [13]. Delir-
ium can be hyperactive - associated with increased
activity and agitation - or hypoactive - associated with
reduced level of arousal and lack of engagement, or
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mixed. Delirium is associated with poor outcomes [14–17]
such as increased mortality: hazard ratio one year mortality
for hyperactive delirium 1.3, hypoactive 1.6 and mixed 1.25
[18]. Many studies of delirium explicitly exclude people
who are too drowsy to be tested [19], meaning studies of
delirium and mortality are more difficult to interpret. Re-
duced level of arousal of acute onset, in the absence of
trauma, is highly specific to delirium [4, 5, 8]. Hypoactive
delirium is less likely to be recognised than cases with
hyperactive features [2, 20, 21] and has poorer outcomes
[18, 21, 22]. The majority of acute medical patients with
reduced level of arousal are likely to have delirium, which
may be undiagnosed, and the majority of these will be older
patients. It is important to establish the association between
reduced level of arousal and mortality.
Objectives
We conducted a systematic review to establish if
reduced level of arousal on admission to hospital with
acute medical conditions is associated with increased
mortality in adult patients.
Methods
This review was reported in accordance with the Pre-
ferred Reporting of Items in Systematic Reviews and
Meta-Analyses (PRISMA) guidance [23].
Protocol and registration
The protocol was prospectively registered on Pros-
pero: http://www.crd.york.ac.uk/PROSPERO/ (reference
CRD42016022048).
Eligibility criteria
The pre-determined inclusion criteria were (1) adults
with acute medical illnesses requiring admission to hos-
pital, (2) patients in emergency departments, acute med-
ical units, acute receiving units, acute geriatric units,
medical assessment units or equivalent, (3) patients in
whom an assessment of level of arousal was made using
either (i) a validated scale (e.g. GCS, AVPU, RASS or
OSLA) or (ii) a subjective description (e.g. drowsy), (4)
in-hospital mortality data comparing a drowsy group
with a non-drowsy or less drowsy group.
The pre-determined exclusion criteria were (1) studies
including children, (2) studies excluding patients aged
over 65, (3) studies solely in intensive care units, (4) pa-
tients with a surgical condition given these patients may
have undergone trauma, or early surgery and thus have
exposure to anaesthetic agents, (5) studies solely includ-
ing patients with direct central nervous system injuries:
trauma, stroke, brain abscess, brain tumour, meningitis
and encephalitis, (6) patients with poisoning, post
drowning or post cardiac arrest. The protocol was al-
tered to exclude patients with epilepsy and tropical
diseases. Neither condition are typical of reduced level
of arousal associated with general medical illness. If
studies had a mixed population where less than half of
the population had excluded conditions, these studies
were included to reflect the case mix seen in general
medical wards.
Data sources
An inclusive search strategy was developed with an ex-
perienced librarian. The following data sources were
searched in January 2016, and the search updated in
June 2017: (1) Ovid MEDLINE (R) 1946 to present with
daily update, (2) Ovid MEDLINE (R) In-process and
other non-indexed citations, (3) Embase (1974 onwards)
(Additional file 1: Appendix 1). We asked experts from
the European Delirium Association and American Delir-
ium Society to identify any additional references. The
grey literature was not searched. We searched for arti-
cles in all languages and non-expertly translated poten-
tially relevant abstracts where possible. We performed
forward citation searches of included articles and
checked reference lists of review articles.
Data Collection
Two reviewers (AT, SB) independently reviewed all titles
and abstracts for eligibility. They then independently eval-
uated full texts for inclusion, resolving any disagreement
by discussion. Data extracted by each reviewer comprised:
type of study, condition studied, age range with descriptive
statistics setting, sample size, prevalence of drowsiness,
arousal scale used to evaluate drowsiness and the defin-
ition used, descriptive terms used to describe level of
arousal, in-hospital mortality in the two groups, any
adjustments made to the analysis and the conclusion of
the study. We primarily sought odds ratios (OR) for mor-
tality. If these were not presented in the study, but the raw
data were available, we calculated OR. Where there was
ambiguity over results we contacted authors to clarify.
Risk of Bias Assessment
Risk of bias for each study was assessed using a modified
version of the Risk of Bias Assessment tool for Non-
randomized Studies (RoBANS) [24] (Additional file 1:
Appendix 2).
Synthesis of Results
We performed quantitative analysis using Review
Manager (RevMan) [25]. Dichotomous data were ana-
lysed using a random effects model to calculate a pooled
OR with 95% confidence interval (CI). Statistical hetero-
geneity was quantified using I2 and supplemented by
evaluation of the clinical heterogeneity and inspection of
the forest plot. A sensitivity analysis was performed
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including only those studies which used the Glasgow
Coma Scale to evaluate level of arousal.
Results
Study selection
We identified 21,104 references, from which we sought
133 full texts in the initial search and 2837 references
from which we sought 12 full texts in June 2017 (Fig. 1).
Study characteristics
The review included 21 studies, eight of which comprised
unselected medical admissions [4, 10–12, 26–29] and 13
which considered specific medical conditions [30–42]. All
were cohort studies; 11 prospective and 10 retrospective.
The 21 studies were published between 1990 and 2017
from Europe, Africa, North America, South America and
Asia (Table 1). The sample size varied from 23 to 30,405
(median 469), with a total of 51,921 patients included in the
review population. Mean ages ranged from 33.4 to 83.8
years. In studies with specific medical conditions the
majority was respiratory (n=7), followed by endocrine
(n=3), vasculitis (n=1), cardiology (n=1) and gastro-
intestinal (n=1). Several different scales were used to
assess level of arousal: ten studies used GCS, two used
AVPU, three used the Japan Coma Scale, one used the
Kelly-Matthay scale and one used the Richmond Agita-
tion and Sedation Scale (Additional file 1: Appendix 3).
Three studies defined their own categories to describe
level of arousal. Calle et al [34] described, but did not
define, ‘altered level of consciousness’, however the
paper made clear that these were patients with reduced
level of arousal, rather than agitation. Eight studies did
not present the proportion of patients with reduced
level of arousal; in the remaining 13 studies the prevalence
ranged from 3.1%-76.9% (median 13.5%). Mortality rates
ranged widely, from 1.7%-58% (median 15.9%).
Fig. 1 PRISMA flow chart of study selection
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Risk of bias
Risk of bias was generally high for the consideration of
confounding variables (Fig. 2), with a lack of sufficient
information in individual studies regarding features such
as the presence of dementia, use of sedative drugs, psy-
choactive drugs or alcohol, or inclusion of these features
Fig. 2 Forest plot of association between level of arousal and mortality
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in multivariate analyses. The risk of confounding bias
was only deemed low in one study [40], which consid-
ered both dementia and psychoactive medication use.
Selection of patients and incomplete data outcome were
variable (Additional file 1: Appendix 4). Most studies
used a known scale to measure level of arousal, therefore
the risk of bias from measurement of exposure was low,
although training in using the scales was not reported.
None of the studies had published a protocol, therefore
the risk of selective outcome reporting was unknown.
Quantitative results
A wide range of scales were used to assess level of arousal.
Different cut-offs were used to define the categories of
drowsy and non-drowsy/less drowsy making direct com-
parison impossible across included studies. Multivariate
analysis was performed on 16 of the studies; however, the
potential confounding factors included in the analysis var-
ied greatly (Additional file 1: Appendix 5). Raw data was
available for 12 studies and two authors [12, 33] provided
raw data to allow inclusion in meta-analysis.
Reduced level of arousal was associated with increased
inpatient mortality (pooled OR 5.71 95% CI 4.21-7.74;
21,198 patients, low quality evidence: risk of bias, clin-
ical heterogeneity, risk of publication bias). There is sig-
nificant heterogeneity with an I2 of 64%. This can be
explained by the variation in medical conditions studied
and range of scales used. Two further studies[29, 36] re-
ported the association between reduced level of arousal
and mortality as: OR 5.10 95% CI 3.10-8.39, OR 5.65
95% CI 3.35-9.53, event rates were not available so these
data could not be pooled.
Sensitivity analysis including only those studies using
GCS confirmed the direction of the observed effect with
a pooled OR of 9.16 (95% CI 6.37-13.18; 7,381 patients,
low quality evidence due to risk of bias and clinical
heterogeneity).
Data from a further five studies could not be pooled as
there was insufficient data available to calculate a univar-
iate OR [11, 26, 28, 30, 37]. In patients with COPD sur-
vivors had a lower mean score (2) using the Kelly
Matthay Scale [30] (see Additional file 1: Appendix 3)
than those who died. Nursing home patients with med-
ical admissions[28] reported “GCS at the time of admis-
sion was significantly associated with in-patient death”:
OR 0.877 (99% CI 0.792-0.970), that is, higher GCS was
associated with reduced mortality. On multivariate ana-
lysis the hazard ratio for survival for ‘low GCS’ was
0.924 (99% CI 0.880-0.970). Mean GCS levels were 11.8
(+/-3.2) in survivors with hyperglycaemic, hyperosmolar
non-ketotic states [37] versus 7.7 (+/-4.3) for those who
died in-hospital (95% CI of the difference -5.8 to -2.3).
On multiple logistic regression low GCS on admission
was the only factor contributing to death (OR 14.012
p<0.001 (no CI given)). A cohort of unselected patient-
s[11]found mean GCS of 14 (+/-2) in survivors and 13
(+/-3) in non-survivors. On multivariate analysis GCS
was reportedly an independent predictor of mortality: OR
0.883 (95% CI 0.790-0.988) which was the OR of higher
GCS and mortality. A preliminary study looking at early
warning scores (EWS) [26] showed mean GCS was 13.1 in
those who died versus 14.8 in survivors, p=0.2330. No
multivariate analyses were performed. This was the only
study which did not find a statistically significant associ-
ation between reduced level of arousal and in-hospital
mortality. It was however small (n=167) with only ten
deaths and the risk of bias was either high or unclear in all
categories.
Risk of bias across studies
The funnel plot (Additional file 1: Appendix 6) suggests
that there may be publication bias against negative small
studies.
Discussion
Summary of findings
This systematic review and meta-analysis demonstrates
that acute medical patients with reduced level of arousal
on admission to hospital have a substantially higher risk of
mortality compared with those with normal or heightened
level of arousal. The meta-analysis, performed using 14 of
the 21 studies, found reduced level of arousal was associ-
ated with a 5.7-fold increased risk of in-hospital mortality.
We felt it was important to perform a meta-analysis on
these studies to confirm the underlying effect size. Sensi-
tivity analysis including only those studies using GCS- the
most widely used clinical arousal test, which has been in
use without change for several decades- confirmed the
direction of the observed effect with a pooled OR of 9.16.
This was performed to reduce the degree of heterogeneity
but note significant clinical heterogeneity remains. Studies
not included in the meta-analysis showed results in the
same direction, but some upper confidence intervals
were close to one, suggesting some overlap between
the group. This occurred in three studies. These stud-
ies were generally small and used different cut-offs to
determine low and high GCS. Meta-regression was
not performed due to heterogeneity of studies.
These findings have important caveats in that the in-
cluded studies were heterogeneous in the populations
studied and methods used to measure level of arousal.
Although overall we considered the available evidence to
be of low quality the consistency between studies in
demonstrating a positive association between reduced
level of arousal and mortality and the narrow CI for the
pooled data is notable.
Delirium is also associated with increased mortality
[15–18] and the majority of patients with acute-onset
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reduced level of arousal meet criteria for delirium [4, 5,
8, 13]. Additionally, some delirium studies exclude patients
with severely reduced level of arousal [19]; this restricted
spectrum may have led to underestimation of the relation-
ship between delirium diagnosis and mortality.
The 5.7-fold mortality rate can be compared with other
illness severity indicators: for example raised lactate (>4
mmol/L) on admission to hospital has an OR for in hos-
pital mortality of four (95% CI 1.7-14.1) [43–45] and
hypotension <100mmHg has an OR of 2.0 (95% CI 1.3-2.8)
[46] and <90mmHg OR 3.88 (95% CI 2.62-5.75) [47].
Strengths of the review
This was a large and comprehensive systematic review
evaluating over 23,000 references using an inclusive
search strategy. All references, abstracts and full texts
were assessed by two independent reviewers. We trans-
lated articles as able, followed up conference abstracts
and performed forward citation searches. We contacted
authors for data and clarification. In light of predicted
significant heterogeneity, a random effects model was
used in the meta-analysis.
Limitations of the review
It is possible that relevant studies could have been missed.
We did not include non-published studies or the grey lit-
erature. We were able to translate five non-English studies
but there remained nine we could not translate. No full
text was available for 28 abstracts; mainly conference ab-
stracts. We searched for future publication of full text for
these articles but none were identified. Not all studies pre-
sented the data required to calculate OR but available data
was increased following correspondence with study au-
thors. Another three study authors attempted to retrieve
their raw data but were unable. The available evidence
from the studies included in this review was considered of
low quality overall, due to the risk of bias, clinical hetero-
geneity and the risk of publication bias. However, similar
results were found if studies that were retrospective and/
or used no validated arousal scale, were removed.
Interpretation and implications for clinical practice and
further research
No previous systematic review has explored the relation-
ship between reduced level of arousal and mortality. We
were unable to explore the reasons underpinning this as-
sociation. It is possible that patients with reduced level
of arousal had more severe illness, however, multivariate
analyses suggest reduced level of arousal is still associ-
ated with increased mortality after correcting for vital
signs, and thus this is unlikely to be the sole explanation.
It is plausible that reduced level of arousal contributes
causally to poor outcomes, through increased risk of as-
piration pneumonia, increased practical challenges of
providing medical care, and impairing the ability to
undergo rehabilitation.
The poor prognosis of delirium is increasingly recog-
nised [14–17]. The majority of studies did not present
sufficient information to allow us to comment on the
presence of delirium, but it is established that acute-
onset reduced level of arousal, in non-comatose patients,
is a highly specific indicator of delirium [4, 5, 8, 13].
Only two [4, 34] of the included studies looked for delir-
ium amongst their patients. Many studies of delirium
specifically exclude patients with reduced level of arousal
[19]. Given the 5.7-fold increased risk of in-hospital
mortality in this group clinicians need to be vigilant regard-
ing these patients, consider discussion around prognosis
with patients and families, and actively seek evidence to
diagnose delirium and manage it appropriately.
Future research should examine the outcomes of both
reduced level of arousal and delirium, considering likely
aetiologies and causes of death. This would require pro-
spective cohort studies evaluating sufficient numbers of
patients, including those with primary neurological dis-
ease and/or surgical conditions for predetermined sub-
group analyses. Validated level of arousal scales should
be used rather than descriptive terms. Comprehensive
characterisation of patient demographics, co-morbidities
including dementia, drugs (particularly use of psycho-
active or sedative drugs) and alcohol use should be re-
ported. Delirium studies should include patients who are
too drowsy to undergo cognitive testing or interview.
This could be achieved by using specific level of arousal
assessment instruments, or by using delirium scales with
embedded level of arousal measurement such as the 4
“A”s Test (4AT) [48].
Conclusions
In this systematic review and meta-analysis, reduced
level of arousal on admission to hospital with general
medical illnesses is associated with a 5.7-fold increased
risk of in-hospital mortality. Patients with reduced level
of arousal should therefore be identified as having a high
risk of in-hospital death, and their care should take this
into account. As acutely reduced level of arousal is a
strong indicator of delirium, patients with reduced level
of arousal should be assessed for delirium, and follow a
delirium management pathway if diagnosed.
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